Targeting Na+/K+‐translocating adenosine triphosphatase in cancer treatment

E-ISSN： 1440-1681|42|5|427-443

ISSN： 0305-1870

Source： CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol.42, Iss.5, 2015-05, pp. : 427-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TREK‐1 and TASK‐3 in depression

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 3, 2015-02 ,pp. : 771-784

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting Social and Economic Correlates of Cancer Treatment Appointment Keeping among Immigrant Chinese Patients

By Gany Francesca Ramirez Julia Chen Serena Leng Jennifer

Journal of Urban Health: Bulletin of the New York Academy of Medicine, Vol. 88, Iss. 1, 2011-02 ,pp. : 98-103

Springer Publishing Company

Access to resources Recommend Favorite

Interventions targeting absences increase adherence and reduce abandonment of childhood cancer treatment in El Salvador

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 9, 2015-09 ,pp. : 1609-1615

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment dynamics of bone‐targeting agents among men with bone metastases from prostate cancer in the United States

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 2, 2018-02 ,pp. : 229-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 111-116

Bentham Science Publishers

Access to resources Recommend Favorite